Pharma programmatic strategy, written down
200 practical guides on healthcare programmatic media, organized into 20 series. Each series opens with a guide that frames the decision, then nine articles that go one level deeper. Search, filter by topic, or jump to a series.
- 01Pharma programmatic strategy and media investment
- 02HCP targeting, NPI audiences, and provider engagement
- 03DTC strategy, patient audiences, and healthcare journeys
- 04Health data evaluation, identity, and interoperability
- 05Rx attribution, incrementality, and measurement design
- 06Healthcare CTV, online video, and cross-channel planning
- 07DSP evaluation, inventory quality, PMPs, and supply paths
- 08Pharma agency partnerships and stakeholder leadership
- 09Campaign planning, optimization, pacing, and analytics
- 10AI applications and emerging healthcare media developments
- 11HCP engagement strategy and analytics
- 12NPI targeting and HCP programmatic advertising
- 13Pharmaceutical marketing strategy fundamentals
- 14DTC pharma marketing and patient engagement
- 15Healthcare programmatic advertising
- 16Pharma marketing compliance and privacy
- 17Healthcare CTV, OTT, and TV measurement
- 18Rx outcomes measurement platforms and methods
- 19Diagnostic data and precision medicine commercialization
- 20Programmatic media quality and buying concepts explained
Showing all 200 articles
No articles match that search. Try a broader term, or clear the filter.
Pharma programmatic strategy and media investment
How to decide where pharma media money goes, how much to test, and how to defend the plan to finance. Start with the series guide.
Pharma Programmatic Strategy: An Investment Decision Guide
A decision chain for pharma programmatic strategy, from commercial objective to audience, channel, budget, measurement, and learning agenda.
4 min read → Strategy & InvestmentHow to Allocate a Pharma Programmatic Budget Across Audiences, Channels, and Tests
Allocate pharma programmatic budgets by business objective, audience constraint, channel role, evidence quality, and marginal return.
3 min read → Strategy & InvestmentWhen to Scale, Hold, or Stop a Pharma Media Pilot
Set evidence, quality, and economics gates that determine whether a pharma media pilot should scale, continue, or stop.
3 min read → Strategy & InvestmentWorking Media vs. Nonworking Costs in Pharma Programmatic
Classify pharma programmatic media, data, technology, measurement, creative, and agency costs without mistaking a higher working-media ratio for value.
3 min read → Strategy & InvestmentScenario Planning for an Uncertain Pharma Media Budget
Build downside, base, and upside pharma media plans with protected capabilities, explicit assumptions, and reallocation triggers.
3 min read → Strategy & InvestmentDirect, PMP, or Open Auction for Pharma Media?
Compare direct, private marketplace, and open-auction buying for pharma across control, scale, transparency, cost, and measurement.
3 min read → Strategy & InvestmentA Pharma Programmatic Partner RFP Scorecard
Evaluate pharma programmatic partners with weighted requirements, evidence levels, failure gates, and a controlled validation plan.
3 min read → Strategy & InvestmentHow Much Budget Should a Pharma Brand Reserve for Learning?
A risk-adjusted way to size a pharma media test budget, based on decision value and opportunity cost rather than a universal percentage.
3 min read → Strategy & InvestmentHow to Write a Pharma Media Investment Thesis
A one-page structure for a pharma media investment thesis that links evidence, assumptions, downside risk, and the decision you are asking leadership to make.
3 min read → Strategy & InvestmentWhy a Cheap CPM Can Produce an Expensive Pharma Outcome
A worked example showing how media price, target reach, quality, and outcome rate combine, and why the lowest CPM often costs more per result in pharma.
3 min read →HCP targeting, NPI audiences, and provider engagement
From NPI list governance to specialty logic, reach denominators, sequencing, and the engagement signals worth trusting. Start with the series guide.
HCP Audience Strategy: From NPI List to Meaningful Engagement
The full HCP audience decision chain in pharma media, from target-list governance and targeting unit to sequencing, engagement signals, and Rx measurement.
3 min read → HCP TargetingHow to Audit an HCP Target List Before Activation
Audit HCP target lists for identity, eligibility, specialty, geography, recency, hierarchy, and activation readiness before media launches.
3 min read → HCP TargetingWhat an NPI Can and Cannot Tell a Pharma Marketer
An NPI identifies a provider. It does not confirm current specialty, practice location, patient mix, or prescribing relevance. Here is how to use it well.
3 min read → HCP TargetingHow to Handle HCP Specialty and Subspecialty Ambiguity
A confidence-tier method for building HCP audiences when specialty signals conflict across NPI taxonomy, claims, and partner data.
3 min read → HCP TargetingIndividual HCPs, Practices, and Health Systems: Choosing the Targeting Unit
A decision tree for choosing whether pharma media should target individual prescribers, practices, or health systems, based on message, influence, data, and measurement.
3 min read → HCP TargetingHow to Sequence HCP Media Across Display, Video, and Professional Channels
A state-based approach to sequencing HCP media, giving each channel a clear job and an observable signal instead of a rigid funnel.
3 min read → HCP TargetingHow to Measure HCP Target-List Reach Without Hiding Denominator Problems
A three-denominator standard for reporting HCP target-list reach so partners cannot inflate coverage by choosing a convenient universe.
3 min read → HCP TargetingWhy HCP Audience Match Rates Differ Across Partners
A reconciliation workflow for comparing HCP match rates across partners by testing denominators, eligibility, identity, geography, and channel rules.
3 min read → HCP TargetingHCP Engagement Metrics: What Each Signal Can Actually Support
An evidence ladder for HCP media metrics, showing which decisions delivery, attention, action, and outcome signals can and cannot support.
3 min read → HCP TargetingHow to Diagnose Low HCP Engagement Without Blaming Creative First
An ordered diagnostic for low HCP campaign engagement that checks delivery, audience, context, and frequency before concluding the creative is the problem.
3 min read →DTC strategy, patient audiences, and healthcare journeys
Patient decision states, audience due diligence, exclusions, caregivers, landing pages, and support handoffs. Start with the series guide.
DTC Pharma Audience Strategy Across the Patient Journey
How to build a DTC pharma audience strategy around patient decision states, data due diligence, context, exclusions, and measurement, without an over-literal funnel.
3 min read → DTC & Patient JourneysA Due-Diligence Checklist for DTC Health Audiences
Vet DTC health audience data for provenance, permissions, construction, recency, identity, validation, activation, and measurement.
3 min read → DTC & Patient JourneysContextual vs. Audience Targeting for DTC Pharma
Compare contextual and audience targeting for DTC pharma by relevance, scale, privacy, identity dependence, control, and measurement.
3 min read → DTC & Patient JourneysHow to Map a Patient Journey Without Inventing a Linear Funnel
A method for turning patient research into a branching journey map with an assumption ledger and testable media implications.
3 min read → DTC & Patient JourneysRare-Disease Audience Strategy Without False Precision
Plan rare-disease audience media with honest scale ranges, signal tiers, privacy review, suppression, and fit-for-purpose measurement.
3 min read → DTC & Patient JourneysHow to Plan DTC Exclusions and Suppression Rules
A purpose-based exclusion register for DTC pharma media covering minors, sensitive contexts, opt-outs, existing patients, and frequency, with owners and review dates.
3 min read → DTC & Patient JourneysCaregiver Audiences in Pharma Media: When the Strategy Changes
How to decide whether caregivers need a distinct pharma media strategy by testing their decision role, message relevance, privacy constraints, and measurement.
3 min read → DTC & Patient JourneysHow to Connect DTC Media With Patient-Support Resources
A handoff checklist from DTC ad to patient support resources, covering message continuity, landing experience, accessibility, and program access.
3 min read → DTC & Patient JourneysDTC Reach and Frequency When the Addressable Audience Is Uncertain
A range-based way to plan DTC pharma reach and frequency when the true size of the addressable audience is unknown, with a sensitivity table.
3 min read → DTC & Patient JourneysHow to Evaluate a DTC Pharma Landing Experience
A joint media and content checklist for DTC pharma landing pages covering message match, speed, risk information, accessibility, and next steps.
3 min read →Health data evaluation, identity, and interoperability
How to vet health audience data: provenance, permission, identity graphs, freshness, and the contract terms that enforce it. Start with the series guide.
Health Audience Data and Identity: A Buyer's Evaluation Guide
An evidence chain for evaluating health audience data and identity, from source and permission to match, activation, and outcome.
3 min read → Health Data & IdentityDeterministic vs. Probabilistic HCP Identity
Compare deterministic and probabilistic HCP identity by evidence, coverage, error risk, channel, reporting, and campaign use case.
3 min read → Health Data & IdentityHow to Evaluate an Identity Graph for Healthcare Media
An evidence sheet for identity graphs used in healthcare media that separates coverage, correctness, freshness, and fitness for a specific use.
3 min read → Health Data & IdentityHealth Data Provenance: Questions Every Audience Vendor Should Answer
A source-to-segment lineage template and the provenance questions every health audience vendor should answer before a pharma brand buys.
3 min read → Health Data & IdentityHow to Measure Audience Overlap Before Buying More Data
Measure duplication, unique reach, and marginal cost across pharma audience vendors before adding another data partner.
3 min read → Health Data & IdentityConsent, Permission, and Fitness for Use Are Not the Same Thing
A three-gate model for health data in pharma marketing that separates legal permission, contractual permission, and whether a use fits the brand's standards.
3 min read → Health Data & IdentityData Freshness in Healthcare Audiences: How Old Is Too Old?
A change-rate and decision-risk model for setting refresh requirements on healthcare audience data, instead of one universal freshness threshold.
3 min read → Health Data & IdentityHousehold Identity in DTC Pharma: Uses, Limits, and Spillover
When household-level targeting fits DTC pharma, where it fails, and a risk matrix for intended and unintended exposure on shared devices.
3 min read → Health Data & IdentityWhat Interoperability Means in a Healthcare Media Data Flow
The four kinds of interoperability in healthcare media data flows (syntactic, semantic, identity, and operational) and how each breaks.
3 min read → Health Data & IdentityA Health Audience Data Contract Checklist for Marketers
Operational contract questions for marketers buying health audience data, covering permitted use, deletion, audit rights, subprocessors, and measurement. Not legal advice.
3 min read →Rx attribution, incrementality, and measurement design
Attribution versus incrementality, holdouts, windows, match rates, forecasts, and how to stress-test a result. Start with the series guide.
Pharma Media Measurement Design: From Exposure to Incremental Rx
How to match each pharma media decision to the minimum measurement design that can support it, from delivery checks to incremental Rx studies.
3 min read → Measurement & Rx AttributionAttributed Prescriptions vs. Incremental Prescriptions
Understand why attributed prescriptions and incremental prescriptions answer different questions, and how to use each in pharma media decisions.
3 min read → Measurement & Rx AttributionHow Rx Attribution Works: Matches, Windows, and Comparison Groups
A plain explanation of how pharma Rx attribution links ad exposure to prescriptions, where the data can fail, and what questions to ask a measurement partner.
3 min read → Measurement & Rx AttributionWhy an Rx Match Rate Drops and How to Diagnose It
Diagnose Rx match-rate declines across eligibility, identifiers, identity resolution, consent, platform delivery, claims coverage, and timing.
3 min read → Measurement & Rx AttributionHow to Design a Holdout Test for Pharma Media
Design pharma media holdouts with clear units, randomization, contamination controls, power, outcome windows, and preplanned analysis.
3 min read → Measurement & Rx AttributionStatistical Significance vs. Commercial Importance in Pharma Media
Interpret pharma media tests using effect size, uncertainty, power, decision thresholds, scalability, and commercial value.
3 min read → Measurement & Rx AttributionHow to Choose an Rx Attribution Window
Select pharma Rx attribution windows using clinical journey, media role, claims lag, prior behavior, and sensitivity analysis.
3 min read → Measurement & Rx AttributionHCP-Level vs. Geographic Pharma Measurement Designs
A design choice matrix comparing HCP-level test-and-control and geographic experiments for pharma media, covering spillover, sample size, control, and privacy.
3 min read → Measurement & Rx AttributionHow to Forecast Incremental Prescriptions Without Pretending Certainty
Build transparent, range-based incremental prescription forecasts from eligible reach, baseline behavior, lift, match coverage, and uncertainty.
3 min read → Measurement & Rx AttributionMeasurement Sensitivity Analysis for Pharma Media
How to stress-test pharma media measurement conclusions by changing one assumption at a time and noting when the recommendation reverses.
3 min read →Healthcare CTV, online video, and cross-channel planning
Assigning jobs to CTV, online video, and YouTube, then controlling quality, frequency, accessibility, and reach. Start with the series guide.
Healthcare Video Strategy Across CTV, Online Video, and YouTube
How to assign clear jobs to CTV, online video, and YouTube in healthcare media before splitting budget, with quality, frequency, and measurement in view.
3 min read → CTV & VideoCTV vs. Online Video for Pharma: How to Allocate the Roles
Compare CTV and online video for pharma by viewing environment, targeting, creative, supply, frequency, action, and measurement.
3 min read → CTV & VideoA Pharma Video Quality Scorecard Beyond Completion Rate
Evaluate pharma video using valid delivery, placement, viewability, audibility, suitability, frequency, audience quality, and outcomes.
3 min read → CTV & VideoCTV Frequency Management for Pharma Campaigns
Manage pharma CTV frequency across households, apps, publishers, DSPs, and direct buys with identity-aware reporting and marginal reach rules.
3 min read → CTV & VideoHow to Test Incrementality in Pharma CTV
A feasibility matrix for household holdouts, geographic tests, and matched-control designs in pharma CTV, with the assumptions each relies on.
3 min read → CTV & VideoSmall-Audience Video Planning for Rare and Specialty Conditions
How to plan video for rare and specialty pharma brands when audiences are small, including minimum reportable cells, reach limits, and privacy safeguards.
3 min read → CTV & VideoYouTube vs. Open-Web Video for Pharma
Compare YouTube and open-web video for pharma across access, targeting, placement, controls, transparency, frequency, and measurement.
3 min read → CTV & VideoHow to Audit a Pharma CTV Supply Chain
Audit pharma CTV supply from app identity and seller authorization through auction path, placement quality, fees, and outcomes.
3 min read → CTV & VideoAccessible Video Creative in Healthcare Marketing
A media-delivery checklist for accessible healthcare video, covering captions, audio description, readable on-screen text, and channel constraints.
3 min read → CTV & VideoHow to Measure Deduplicated Reach Across CTV and Online Video
How to report cross-channel video reach honestly by separating observed, modeled, and unavailable duplication between CTV and online video.
3 min read →DSP evaluation, inventory quality, PMPs, and supply paths
Choosing a DSP on evidence, cleaning up supply paths, validating PMPs, and reconciling every fee. Start with the series guide.
How to Evaluate a DSP for Pharmaceutical Advertising
A requirements-to-evidence process for choosing a demand-side platform for pharma, covering health data, controls, supply, measurement, and fees.
3 min read → DSPs & Supply QualityHow to Write DSP Requirements Before Watching Demos
Define pharma DSP requirements for audience, identity, supply, controls, measurement, workflow, data access, privacy, and commercials before demos.
3 min read → DSPs & Supply QualityQuestions to Ask in a Healthcare DSP Demo
Scenario-based questions for healthcare DSP demos that require live evidence in the platform instead of slides, covering targeting, controls, supply, and reporting.
3 min read → DSPs & Supply QualitySupply Path Optimization for Pharma: What to Remove and Why
A removal rule for pharma supply path optimization that balances transparency, uniqueness, performance, cost, and resilience instead of cutting paths blindly.
3 min read → DSPs & Supply QualityHow to Evaluate Pharma PMPs Before Committing Budget
A deal evidence card and pre and post-launch validation checklist for private marketplace deals in pharma programmatic.
3 min read → DSPs & Supply QualityDSP Fee Transparency: A Pharma Buyer's Reconciliation Guide
How to reconcile DSP invoices to log-level data with a cost waterfall that separates media, platform, data, verification, and unexplained differences.
3 min read → DSPs & Supply QualityWhat Log-Level Data Should a Pharma Advertiser Request?
Minimum log-level data field sets by use case for pharma programmatic, plus a review of fields you should not collect for privacy reasons.
3 min read → DSPs & Supply QualityHow to Use ads.txt, sellers.json, and SupplyChain Objects Together
A worked trace showing what ads.txt, sellers.json, and the SupplyChain object each prove about a programmatic impression, and what they cannot prove.
3 min read → DSPs & Supply QualityInventory Quality vs. Audience Quality in Pharma Media
A two-axis diagnostic that keeps inventory quality and audience quality separate, so one strong dimension does not hide a weak one in pharma media.
3 min read → DSPs & Supply QualityHow to Diagnose a Sudden Change in Programmatic Inventory Mix
A change-point checklist for sudden shifts in pharma programmatic domain, app, or deal mix, tied to likely causes and the evidence that confirms each.
3 min read →Pharma agency partnerships and stakeholder leadership
Operating models, RACIs, briefs, QBRs, escalation, agency evaluation, and turning results into budget decisions. Start with the series guide.
A Pharma Media Operating Model for Brands, Agencies, Data, and Measurement Partners
How to design a pharma media operating model that maps decisions, evidence, owners, cadence, and escalation across brand, agency, data, and measurement partners.
3 min read → Agency & LeadershipA RACI for Pharma Brand, Agency, Data, and Measurement Teams
Clarify pharma media decision rights across brand, agency, activation, data, analytics, measurement, regulatory, privacy, and procurement teams.
3 min read → Agency & LeadershipHow to Write a Pharma Programmatic Brief That Partners Can Execute
A pharma programmatic brief structure with objective, audience, constraints, measurement, and approval gates, plus ambiguity checks before it goes to partners.
3 min read → Agency & LeadershipHow to Run a Pharma Media QBR That Changes Investment Decisions
Turn pharma media QBRs into decision forums with evidence, tradeoffs, forward scenarios, owners, and documented commitments.
3 min read → Agency & LeadershipAgency Compensation and Incentives in Programmatic Media
Evaluate agency fees and incentives across commission, retainer, FTE, project, and outcome-linked models with transparency safeguards.
3 min read → Agency & LeadershipA Partner Escalation Framework for Pharma Media
Classify pharma media incidents by severity, contain risk, preserve evidence, assign owners, communicate clearly, and verify remediation.
3 min read → Agency & LeadershipHow to Evaluate an Agency's Pharma Programmatic Capabilities
Capability tests for evaluating an agency's pharma programmatic skills using work samples and operating scenarios instead of pitch decks.
3 min read → Agency & LeadershipIn-House, Agency, or Hybrid Programmatic for Pharma?
A total-capability comparison of in-house, agency, and hybrid programmatic models for pharma, including governance, talent, continuity, and cost.
3 min read → Agency & LeadershipHow to Translate Media Results Into a Commercial Investment Case
Translate media evidence into a finance-ready investment case using causal strength, ranges, marginal economics, risks, options, and decision triggers.
3 min read → Agency & LeadershipThe First 90 Days for a Pharma Programmatic Associate Director
A 30-60-90 day operating plan for pharma programmatic leaders covering governance, portfolio diagnosis, measurement, talent, partners, and investment.
3 min read →Campaign planning, optimization, pacing, and analytics
Prelaunch QA, tag validation, frequency caps, pacing diagnostics, weekly optimization, and honest reporting. Start with the series guide.
Pharma Programmatic Campaign Planning and Optimization Guide
How pharma programmatic campaigns move from plan to launch, pacing, optimization, and analysis, with reversible changes separated from risky ones.
3 min read → Campaign OperationsA Prelaunch QA Checklist for Pharma Programmatic Campaigns
An evidence-and-owner prelaunch QA checklist for pharma programmatic campaigns, with hard stops separated from warnings.
3 min read → Campaign OperationsHow to Validate Pharma Measurement Tags Before Launch
A test matrix for validating pharma measurement tags before launch, covering firing, deduplication, parameters, privacy, and downstream receipt.
3 min read → Campaign OperationsFrequency Caps in Pharma Programmatic: How to Set and Revisit Them
How to set pharma programmatic frequency caps as testable hypotheses with escalation triggers, instead of copying a universal benchmark.
3 min read → Campaign OperationsWhat to Do When a Pharma Campaign Underdelivers
A constraint ladder for diagnosing pharma programmatic underdelivery, checking setup, approvals, audience, inventory, and bids before loosening safeguards.
3 min read → Campaign OperationsHow to Diagnose Overpacing Before Cutting Bids
A root-cause tree for pharma programmatic overpacing that separates setup, supply, and allocation problems before bids are cut.
3 min read → Campaign OperationsA Weekly Pharma Programmatic Optimization Framework
A weekly optimization routine for pharma programmatic built on a decision journal: expected effect, risk, and evaluation date for every change.
3 min read → Campaign OperationsHow to Interpret Reach, Frequency, and Duplication Together
A four-scenario matrix for reading reach, frequency, and duplication together in pharma media reports, to avoid optimizing a single metric.
3 min read → Campaign OperationsClicks, Site Visits, and Conversions: A Pharma Funnel Diagnostic
A reconciliation waterfall for pharma media that separates measurement loss from real user loss between clicks, site visits, and conversions.
3 min read → Campaign OperationsHow to Build a Pharma Media Performance Narrative Without Cherry-Picking
How to write a pharma media performance narrative that uses predeclared criteria, includes contrary signals, and states uncertainty plainly.
3 min read →AI applications and emerging healthcare media developments
Governing AI in healthcare marketing, testing AI recommendations, and what site owners can control about AI search. Start with the series guide.
AI in Healthcare Media: A Governance and Use-Case Guide
How to classify AI use cases in healthcare media by data sensitivity, decision impact, and review burden, and set governance that fits each.
3 min read → AI in Healthcare MediaWhere Generative AI Can Assist a Pharma Media Team
A value-risk matrix for generative AI in pharma media, separating assistive work like drafting and QA from consequential decisions that need tighter control.
3 min read → AI in Healthcare MediaHow to Evaluate an AI-Generated Pharma Media Plan
A red-team checklist for AI-generated pharma media plans covering invented facts, hidden assumptions, source quality, math consistency, and feasibility.
3 min read → AI in Healthcare MediaUsing AI for Campaign Analysis Without Exposing Sensitive Data
A data-classification gate and safe substitution workflow for using AI tools on pharma campaign data without exposing health or confidential information.
3 min read → AI in Healthcare MediaHuman Review for AI-Assisted Healthcare Marketing
A review-intensity matrix for AI-assisted healthcare marketing, based on potential harm, reversibility, and public exposure, with clear reviewer accountability.
3 min read → AI in Healthcare MediaHow to Test an AI Optimization Recommendation Before Acting
A shadow-mode and bounded-test sequence for AI media optimization recommendations that prevents silent automation drift in pharma campaigns.
3 min read → AI in Healthcare MediaSynthetic Audiences in Healthcare Media: Questions Before Use
A claim-and-validation checklist for synthetic and modeled audiences in healthcare media that separates privacy benefits from predictive validity.
3 min read → AI in Healthcare MediaHow to Audit Bias in an AI-Assisted Healthcare Audience Model
A subgroup evaluation plan for AI-assisted healthcare audience models, tied to intended use, representativeness, missing data, and drift.
3 min read → AI in Healthcare MediaAI Search Visibility for Healthcare Expertise: What Site Owners Can Control
What healthcare site owners can and cannot control about AI search visibility, separating content quality, crawler access, structured data, and training controls.
3 min read → AI in Healthcare MediaHow to Monitor AI Search Citations Without Treating Them as Rankings
A repeatable query panel and observation log for tracking AI search citations, with explicit sampling limits so results are not mistaken for rankings.
3 min read →HCP engagement strategy and analytics
What HCP engagement actually means, how to measure it across the journey, and how tiering, segmentation, sentiment, and ROI fit together. Start with the series guide.
HCP Engagement: What It Means and How Pharma Teams Build It
HCP engagement means a prescriber has moved through observable states, from reached to acting. Here is how pharma teams define, build, and measure it.
10 min read → HCP EngagementHow to Measure HCP Engagement at Every Step of the HCP Journey
How to measure pharma HCP engagement at every step of the HCP journey, with the metric, data source, and owner for each stage and the gaps between them.
6 min read → HCP EngagementHow to Measure ROI on HCP Marketing Spend
How do you measure ROI on HCP marketing spend? Use incremental Rx, net revenue per script, margin, and full cost. A worked hypothetical example shows the math.
6 min read → HCP EngagementMeasuring HCP Sentiment: Surveys, Field Feedback, and Media Signals
Measuring HCP sentiment works best when you combine ATU surveys, field feedback, and content signals and account for the bias each method carries.
6 min read → HCP EngagementHCP Tiering: How to Prioritize Prescribers Without Overfitting to Volume
HCP tiering ranks prescribers so field and media effort goes where it can change behavior. Here is how to blend deciles, potential, access, and new writers.
6 min read → HCP EngagementHCP Segmentation Models: Behavioral, Attitudinal, and Channel Preference
An HCP segment is only useful if it changes what you do. Compare behavioral, attitudinal, and channel preference models and how to make them work in media.
6 min read → HCP EngagementKOL Engagement and Digital Media: Where They Connect
How HCP KOL engagements in medical affairs relate to commercial digital media, where the firewall sits, and how peer influence content stays compliant.
6 min read → HCP EngagementHCP Outreach Across Field, Email, and Programmatic: Coordinating the Mix
HCP outreach works when field, email, and programmatic share contact rules, suppression windows, and an NPI-level data feed. Here is how to set them up.
6 min read → HCP EngagementHCP Engagement Analytics: The Data Problems Teams Hit First
HCP engagement analytics breaks on identity, channel silos, Rx lag, attribution, small samples, and consent. Here is a fix for each one marketers hit.
6 min read → HCP EngagementOpen Payments and HCP Transparency Reporting: What Marketers Should Know
Open Payments requires drug makers to report value given to physicians and certain clinicians. What HCP and HCO transparency reporting means for marketers.
6 min read →NPI targeting and HCP programmatic advertising
How NPI-based targeting works in programmatic media, from list building and identity matching to reach expectations by specialty. Start with the series guide.
NPI Targeting: How Pharma Reaches Specific Prescribers in Programmatic Media
NPI targeting lets pharma brands reach a named list of prescribers in programmatic media. How lists become addressable, what match rates mean, and the limits.
9 min read → NPI & HCP ProgrammaticWhat Is HCP Targeting? A Plain-Language Explainer
What is HCP targeting? A plain explanation of who counts as an HCP, why marketing to them differs from consumer marketing, and the main targeting methods.
6 min read → NPI & HCP Programmatic1:1 HCP Targeting: How It Works and Where It Breaks
1:1 HCP targeting promises ads served to specific NPIs. Here is how deterministic claims are built, what verified means, and how to test a 1:1 claim yourself.
6 min read → NPI & HCP ProgrammaticHow to Build an NPI Target List From Brand Strategy
How to build an NPI target list from brand strategy: specialty, decile, geography, exclusions, list size math, and the file format partners need at handoff.
5 min read → NPI & HCP ProgrammaticNPI Marketing Beyond Display: Email, Field, Point of Care, and Social
NPI marketing reaches more than display. Compare email, field, point of care, social, and CTV channels on how each matches to NPIs and what it can measure.
5 min read → NPI & HCP ProgrammaticHCP Identity Matching: How an NPI Becomes an Addressable Audience
HCP identity matching turns an NPI list into reachable devices and logins. How emails, site logins, device graphs, and hashed IDs work, and why rates differ.
6 min read → NPI & HCP ProgrammaticHCP Audience Generation: Lookalikes, Modeled Lists, and When to Avoid Them
HCP audience generation with lookalikes and modeled lists can add scale. Learn when modeled HCP audiences help, how to validate them, and how to stop drift.
6 min read → NPI & HCP ProgrammaticHCP Programmatic Advertising: Channels, Inventory, and Buying Paths
HCP programmatic advertising runs across endemic sites, open web, PMPs, CTV, and social. What each channel is for and how to choose a buying path for pharma.
5 min read → NPI & HCP ProgrammaticHCP Audience Reach: Setting Realistic Expectations by Specialty Size
HCP audience reach depends on universe size, match rate, and channel mix. How to set a realistic reach ceiling for small and large specialties before launch.
5 min read → NPI & HCP ProgrammaticHCP Marketing as B2B Marketing: What Transfers and What Does Not
Is HCP marketing B2B? Account based marketing ideas transfer to pharma in useful ways, but regulation and prescribing decisions change how they work.
5 min read →Pharmaceutical marketing strategy fundamentals
The fundamentals of how drug brands plan marketing: strategy, HCP vs. DTC, physicians, paid search, launch, lifecycle, and commercial models. Start with the series guide.
Pharmaceutical Marketing Strategies: A Framework for Brand Teams
A practical framework for pharmaceutical marketing strategies, from market definition and audiences to positioning, channel mix, compliance, and measurement.
11 min read → Pharma Marketing BasicsHCP vs. DTC Marketing: How the Two Tracks Differ and Work Together
HCP vs DTC marketing compared on audience, rules, channels, data, measurement, and budget, plus how to tell when a drug brand needs both tracks.
6 min read → Pharma Marketing BasicsPharmaceutical Marketing to Physicians: Channels, Rules, and What Doctors Ignore
How pharmaceutical marketing to physicians works: reps, digital, journals, point of care, PhRMA Code basics, and the attention limits doctors bring.
6 min read → Pharma Marketing BasicsPharmaceutical PPC Advertising: Paid Search Rules and Tactics
How pharmaceutical PPC advertising works under Google policy and FDA rules: certification, branded and unbranded keywords, fair balance, and landing pages.
6 min read → Pharma Marketing BasicsTarget Marketing in Pharma: Segmentation, Targeting, and Positioning
Target marketing in pharma explained through segmentation, targeting, and positioning, with a hypothetical drug brand example for HCP and patient audiences.
6 min read → Pharma Marketing BasicsPharmaceutical Campaign Planning: A Step-by-Step Process
A ten step pharmaceutical campaign planning process from objective and audience to MLR review, launch, optimization, and readout, with a working timeline table.
6 min read → Pharma Marketing BasicsDrug Launch Marketing: The Media Plan From Pre-Launch to Year One
How to build a drug launch marketing media plan, from pre-approval disease awareness to launch day, the first 90 days, and year one measurement gates.
6 min read → Pharma Marketing BasicsPharma Marketing Across the Product Lifecycle
How pharma marketing changes across the product lifecycle, from launch and growth to maturity and loss of exclusivity, with an illustrative budget table.
5 min read → Pharma Marketing BasicsPharmaceutical Ads: Formats, Required Elements, and What Makes Them Work
Pharmaceutical ads and direct to consumer ads by format: print, TV, banners, social, and search, plus required risk elements and what makes creative work.
6 min read → Pharma Marketing BasicsPharma Commercial Models: How Field, Digital, and Media Teams Fit Together
How the pharma commercial model works across rep-led, hybrid, digital-first, and key account approaches, and how media team roles change in each pharma model.
6 min read →DTC pharma marketing and patient engagement
How direct-to-consumer drug marketing works in the US: the challenges, the media mix, condition targeting, programmatic, measurement platforms, and direct-to-patient programs. Start with the series guide.
DTC Pharma Marketing: How Direct-to-Consumer Drug Marketing Works
DTC pharma marketing explained: US rules, the channel mix, condition audiences, measurement, and the 2025 and 2026 regulatory scrutiny brand teams face.
9 min read → DTC MarketingWhat Is DTC in Healthcare? Pharma, Devices, Telehealth, and Direct-to-Patient
What is DTC in healthcare? A plain guide to direct-to-consumer pharma, devices, telehealth, and direct-to-patient programs, and how the rules differ.
6 min read → DTC MarketingThe Biggest Challenges in US DTC Pharmaceutical Advertising
The biggest challenges in US DTC pharmaceutical advertising, from FDA scrutiny and TV costs to privacy limits and measurement lag, and what to do.
6 min read → DTC MarketingPharmaceutical DTC Media Strategy: Building the Channel Mix
A practical pharmaceutical DTC media strategy: what each channel does, how to allocate budget by condition and brand stage, and an illustrative split.
5 min read → DTC MarketingCondition and Ailment Audience Targeting: How It Works and Where the Privacy Lines Are
How ailment audience targeting works for DTC healthcare audiences, where condition data comes from, and the NAI, state law, and consent limits.
6 min read → DTC MarketingDTC Programmatic for Pharma: Where It Fits in the Plan
Where DTC programmatic fits in a pharma media plan: audience versus contextual buying, CTV, sequencing, retargeting limits, and how to judge results.
5 min read → DTC MarketingHow to Choose a DTC Measurement Platform for a Life Sciences Brand
How to choose a DTC measurement platform for a life sciences brand: data source, coverage, privacy, latency, methodology, cost, and a scorecard.
6 min read → DTC MarketingPatient Engagement and DTC Analytics in One Strategy
How pharma teams combine patient engagement and DTC analytics in one strategy, linking media, site, hub, and adherence data with proper consent.
5 min read → DTC MarketingDirect-to-Patient Pharma Programs and What They Change for Media
How direct-to-patient pharma programs change DTC media, measurement, and compliance, plus evaluation factors for DTP healthcare and pharmacy platforms.
5 min read → DTC MarketingDTC Pharma Social Media Advertising: Rules, Formats, and Comment Moderation
DTC pharma social media advertising: fair balance in limited space, FDA draft guidance, influencer disclosures, comment moderation, and safety monitoring.
6 min read →Healthcare programmatic advertising
Programmatic advertising across healthcare, not just pharma: targeting options, contextual, dynamic creative, health systems, devices, endemic media, clean rooms, audio, and DOOH. Start with the series guide.
Programmatic Advertising in Healthcare: How It Works for Pharma, Providers, and Payers
How programmatic advertising in healthcare works for pharma, devices, hospitals, payers, and telehealth, and what makes healthcare programmatic media different.
10 min read → Healthcare ProgrammaticProgrammatic in Pharma: A Glossary of the Terms That Matter
A plain glossary of programmatic in pharma: 45 terms on buying, HCP and DTC audiences, compliance, quality, and measurement, each defined in a sentence or two.
7 min read → Healthcare ProgrammaticHealthcare Programmatic Targeting Options Compared
Healthcare programmatic targeting options compared: NPI, condition audiences, contextual, endemic, geographic, first-party, lookalike, and retargeting.
6 min read → Healthcare ProgrammaticDynamic Targeting and Dynamic Creative in Pharma: What Is Allowed
What dynamic targeting in pharma allows: dynamic creative from approved modules, MLR review of combinations, weather and pollen triggers, and guardrails.
6 min read → Healthcare ProgrammaticPharma Contextual Advertising: How to Build Contextual Segments That Work
How to build pharma contextual advertising segments: keyword vs semantic targeting, adjacent content, negative contexts, and testing against audiences.
6 min read → Healthcare ProgrammaticProgrammatic Advertising for Hospitals and Health Systems
How programmatic advertising for hospitals and health systems works: service-line targeting, geography, HIPAA tracking guidance, and measuring appointments.
6 min read → Healthcare ProgrammaticProgrammatic Advertising for Medical Device Marketing
How programmatic medical device marketing differs from pharma: FDA and FTC device rules, surgeon and facility audiences, DTC devices, and measurement.
5 min read → Healthcare ProgrammaticData Clean Rooms for Pharma Media: Uses and Limits
What data clean rooms do for pharma media: audience overlap, measurement, and activation, plus the privacy review they need and the problems they do not solve.
6 min read → Healthcare ProgrammaticEndemic vs. Non-Endemic Media for Pharma
Endemic vs non-endemic media for pharma: medical publishers, EHR, and point of care compared with open web, CTV, and social on cost, reach, and context.
5 min read → Healthcare ProgrammaticProgrammatic Audio and Digital Out-of-Home for Healthcare
How healthcare brands use programmatic audio and DOOH: podcasts, streaming audio, pharmacy and office screens, audio fair balance rules, and measurement.
6 min read →Pharma marketing compliance and privacy
A working guide to compliance for pharma media teams: fair balance, OPDP letters, HIPAA, state health privacy laws, the FTC rule, MLR, ad types, and tracking governance. Start with the series guide.
Pharma Marketing Compliance: A Working Guide for Media Teams
A working guide to pharma marketing compliance for media teams: who regulates what, what the media team owns, and a checklist by campaign stage.
10 min read → Compliance & PrivacyFair Balance in Digital Pharma Ads: Banners, Video, and Social
What fair balance means in digital pharma ads under 21 CFR 202.1, how ISI works in banners, video, and social, and the format mistakes that cause problems.
8 min read → Compliance & PrivacyOPDP Untitled and Warning Letters: What Media Teams Can Learn
What OPDP untitled letters and warning letters are, the themes that recur, how media format and placement contribute, and how to read the letters on FDA's site.
6 min read → Compliance & PrivacyHIPAA and Pharma Advertising: Where It Applies and Where It Does Not
HIPAA and pharma advertising explained: why manufacturers are usually not covered entities, when HIPAA reaches marketing data, and what tracking guidance means.
7 min read → Compliance & PrivacyState Consumer Health Data Laws and Pharma Media
How state health privacy laws like Washington's My Health My Data Act affect pharma media: consent, sharing, geofencing bans, and what teams must change.
7 min read → Compliance & PrivacyThe FTC Health Breach Notification Rule: What Health Marketers Need to Know
The FTC Health Breach Notification Rule explained for marketers: who it covers after the 2024 update, why pixel sharing can be a breach, and what to check.
7 min read → Compliance & PrivacyWhat Compliance Capabilities to Require From a Pharma Media Agency
What compliance and specialist capabilities a pharma brand should require from its media agency: a checklist for MLR, ISI, adverse events, and privacy.
6 min read → Compliance & PrivacyMLR Review for Programmatic Media: How to Get Faster Approvals
How MLR review works for programmatic media: what reviewers check in creative, targeting, and landing pages, what to submit, and how to speed approvals.
6 min read → Compliance & PrivacyReminder Ads, Help-Seeking Ads, and Product Claim Ads Explained
Reminder ads, help seeking ads, and product claim ads explained: what each FDA ad type can say, when risk information is required, and how media can mix them.
7 min read → Compliance & PrivacyTracking Pixel Governance on Pharma and Health Websites
A practical guide to tracking pixel governance on pharma and health websites: tag inventory, what pixels send, server tagging, consent, and audit cadence.
6 min read →Healthcare CTV, OTT, and TV measurement
CTV and OTT for healthcare buyers, with a focus on measurement: providers, incrementality tools, cross-platform reach, syndicated reach, creative, and household graphs. Start with the series guide.
CTV and OTT Advertising for Healthcare: A Buyer's Guide
A buyer's guide to CTV and OTT healthcare advertising: how the channels differ, buying routes, targeting, pricing drivers, measurement, and pharma rules.
11 min read → CTV MeasurementCTV for HCPs: Can Streaming TV Reach Physicians?
How CTV for HCPs works: matching NPI lists to households, realistic scale, spillover to family members, which messages fit, and how to measure it.
7 min read → CTV MeasurementHow CTV Measurement Providers Differ on Reach, Frequency, and Device Deduplication
How CTV measurement providers differ in reporting reach, frequency, and device deduplication, with panel, ACR, server data, and identity graph methods.
7 min read → CTV MeasurementTools for Measuring CTV Incrementality: Methods and Tradeoffs
The main tools for measuring CTV incrementality, including ghost ads, holdouts, geo tests, matched panels, and MMM, and what each one needs to work.
7 min read → CTV MeasurementMeasuring Reach and Frequency Across Linear TV, CTV, and Online Video
How advertisers can measure reach and frequency across linear TV, CTV, and online video, with cross-platform currencies, dedup methods, and a pharma approach.
7 min read → CTV MeasurementHow to Compare Syndicated Reach Across CTV Partners
How to compare syndication reach across CTV syndication partners: how inventory resale works, why partners overlap, and how to normalize reported reach.
6 min read → CTV MeasurementLinear TV vs. CTV for Pharma DTC: How to Decide the Shift
Linear TV vs. CTV for pharma DTC brands: how audience age, cost, targeting, measurement, and fair balance length should shape the shift in budget.
6 min read → CTV MeasurementPharma CTV Creative: Length, Fair Balance, and Interactive Formats
A guide to pharma CTV creative: choosing 15, 30, or 60 second spots with a major statement, using QR codes, pause ads, and interactive units under MLR review.
7 min read → CTV MeasurementCTV Household Graphs and Healthcare Audience Targeting
How CTV household graphs are built from IP and device data, where accuracy breaks, privacy limits for health segments, and how to test a graph before buying.
6 min read → CTV MeasurementFAST Channels and Ad-Supported Streaming Tiers for Pharma
How pharma brands should evaluate FAST channels and ad-supported streaming tiers: inventory quality, content adjacency, frequency, and buying routes.
6 min read →Rx outcomes measurement platforms and methods
How pharma outcomes measurement platforms work, from Crossix to claims, EHR, and lab data, plus attribution of Rx lift, holdouts, point of care, MMM, and synthetic control. Start with the series guide.
Pharma Outcomes Measurement Platforms: How to Choose and Use Them
A practical guide to pharma outcomes measurement platforms, from Crossix measurement to claims, EHR, and lab data, and how to judge HCP media performance.
10 min read → Measurement PlatformsWhat Is Crossix? How Veeva Crossix Measurement Works
What is Crossix? A plain explanation of Veeva Crossix, how its privacy-safe health data supports audiences and Crossix measurement, and what to ask.
7 min read → Measurement PlatformsHow to Attribute Prescription Lift to Programmatic HCP Media
How to attribute prescription lift to programmatic HCP media, step by step: exposure files, NPI matching, controls, windows, and a worked example.
6 min read → Measurement PlatformsClaims Data vs. EHR Data vs. Lab Data for Campaign Measurement
Comparing claims data, EHR data, and lab data for campaign measurement, and how to judge which real world diagnostic data providers fit your brand outcome.
6 min read → Measurement PlatformsAudience Data Accuracy Validation: What Third-Party Truth Sets Tell You
How third party truth sets such as Truthset validate audience data accuracy, what accuracy scores mean, and where the method falls short for health data.
6 min read → Measurement PlatformsWhat Is a Holdout Test? A Plain-Language Guide for Marketers
What is a holdout test? A plain explanation of how marketers withhold ads from a random group, size the test, read the result, and avoid the common mistakes.
6 min read → Measurement PlatformsHCP Media Performance Reporting: A Monthly Template
A monthly template for HCP media performance reporting: target list reach, frequency, engagement, Rx outcomes, commentary, and the decisions to record.
5 min read → Measurement PlatformsPoint-of-Care Campaign Measurement: Pixels, Conversions, and Physician Engagement
How point of care campaign measurement works, what tracking pixels and conversion events can capture in EHR and clinical apps, and why there is no typical ROI.
7 min read → Measurement PlatformsMarketing Mix Modeling for Pharma: When It Beats Rx Attribution
How marketing mix modeling works for pharma, the data it needs, where it beats Rx attribution for TV and cross channel planning, and how to pair it with tests.
6 min read → Measurement PlatformsSynthetic Control and Matched Market Tests for Pharma Media
How geo tests, matched market tests, and synthetic control work for pharma media, when to use them instead of holdouts, and a hypothetical worked example.
7 min read →Diagnostic data and precision medicine commercialization
How diagnostic and lab data fit into precision medicine launches, HCP targeting, and patient identification, and how to evaluate the vendors that sell it. Start with the series guide.
Diagnostic Data in Precision Medicine Launches: A Commercial Guide
How diagnostic and lab data fits into a precision medicine launch: testing as the bottleneck, HCP targeting by testing behavior, sequencing, and measurement.
10 min read → Precision MedicineHow to Integrate Diagnostic Testing Data Into HCP Targeting
A practical method for adding diagnostic testing data to HCP targeting: NPI linkage, tiering by testing behavior, media triggers, and field coordination.
6 min read → Precision MedicineHow to Judge the Accuracy of Lab and Diagnostic Data for Targeting
How to judge the accuracy and relevance of diagnostic data for HCP targeting: lab coverage, physician attribution, latency, de-identification, and validation.
5 min read → Precision MedicinePatient Identification With Diagnostic Data: Efficiency and Compliance
How to make patient identification with diagnostic data efficient and compliant: HIPAA de-identification, HCP-level signals, and what stays off limits.
6 min read → Precision MedicineHow to Compare HCP Targeting Data Providers for Campaign Measurement
How to compare HCP targeting data providers for campaign measurement, with pros and cons by category: claims, lab, EHR, specialty pharmacy, networks, identity.
5 min read → Precision MedicineHidden Costs in HCP Targeting Data Contracts
Are there hidden costs in HCP targeting data products? A checklist of onboarding, refresh, platform, minimum, and measurement fees to ask about.
6 min read → Precision MedicineHow HCP Data Products Are Priced: Tiers, Licenses, and Usage Fees
How pricing tiers for HCP targeting data products compare: annual licenses, per-CPM usage, per-NPI fees, and project pricing, with a hypothetical example.
6 min read → Precision MedicineIntegrating HCP Data Into CRM, CDP, and DSP Without Breaking Scale
Can HCP targeting data integrate with existing systems at scale without hurting performance? Patterns, identifiers, refresh, governance, and testing.
5 min read → Precision MedicineLaunching a First Precision Medicine at a Small Biotech With Limited Infrastructure
A plan for a small biotech launching its first precision medicine: diagnostic strategy, what to outsource, a minimum viable data stack, and budget phasing.
5 min read → Precision MedicineBiomarker Testing Gaps and How HCP Media Can Help Close Them
Why eligible patients go without biomarker testing and how HCP media can help: testing education, pathology and lab audiences, and measuring testing uplift.
6 min read →Programmatic media quality and buying concepts explained
Plain-language explainers on the programmatic concepts that decide whether healthcare media money works: non-working media, pacing, supply paths, MFA, quality checks, identity graphs, and AI answers. Start with the series guide.
Programmatic Media Quality Explained: A Guide for Healthcare Marketers
Programmatic media quality explained for healthcare marketers: supply paths, viewability, invalid traffic, MFA sites, suitability, audience data, and auctions.
9 min read → Media Quality ExplainedWhat Is Non-Working Media? Definitions and Examples
What is non-working media? A plain definition of working vs non working media, with examples, why programmatic blurs the line, and why it is not waste.
6 min read → Media Quality ExplainedPacing in Programmatic: Overpacing, Underpacing, and Even Delivery Explained
What overpacing and underpacing mean in programmatic, how ASAP and even pacing differ, what causes each problem, and how to read a pacing report before acting.
6 min read → Media Quality ExplainedQuality Path Optimization: Going Beyond Cheapest-Path SPO
Quality path optimization explained: how it differs from supply path optimization, which signals it uses, and how a pharma buyer can put it into practice.
5 min read → Media Quality ExplainedMade-for-Advertising Sites: What They Are and How They Drain Pharma Budgets
Made-for-advertising sites explained for pharma buyers: what MFA sites are, why they pass standard checks, and how to find and exclude them.
6 min read → Media Quality ExplainedViewability, Attention, and Invalid Traffic: The Three Quality Checks
How viewability, attention, and invalid traffic work as quality checks for pharma: the MRC viewability standard, GIVT vs SIVT, and attention limits.
6 min read → Media Quality ExplainedHow to Evaluate a Third-Party Business Identity Graph Before You Use It
Best practices for evaluating accuracy of third-party business identity graphs before marketing automation: truth sets, recency, coverage, pilots.
6 min read → Media Quality ExplainedWhen AI Answers Misrepresent a Healthcare Brand: Risks and Mitigation
The risks of AI engines misrepresenting healthcare brands in YMYL answers, from wrong dosing to off-label claims, and how to monitor and mitigate them.
7 min read → Media Quality ExplainedBrand Safety and Suitability for Pharma: Rules That Do Not Kill Scale
How pharma brand safety and suitability rules work, why keyword blocklists overreach on health news, and how to set and test suitability tiers.
6 min read → Media Quality ExplainedBid Floors, Bid Shading, and Auction Dynamics in Healthcare Programmatic
How bid floors, bid shading, and first-price auctions work in healthcare programmatic, why HCP audiences clear at high prices, and what buyers control.
6 min read →Interactive tools
Free, no signup. Both are stripped-down versions of things I use on real pharma portfolios.
Pharma DSP Picker
Three questions, one directional platform recommendation for an HCP or DTC campaign, built on the criteria that actually decide it.
Open the tool → Tool · Campaign ManagementPortfolio Pacing Dashboard
Pacing, eCPM efficiency, and anomaly flags across a sample 10-brand portfolio, with the written diagnosis behind every flag.
Open the demo →Campaign case studies
Five campaigns I planned, activated, or measured, written up with the result and the limits of the measurement behind it. If you are hiring and want to see how I think, start here.
Taking an HCP Buy Off the Open Exchange
Completion rate climbed from 51.95% to 59.97% and held every day, with a portfolio Rx efficiency read alongside it.
Read case study → Case Study · Audience DataFive Percent of the Budget, Half the Incremental Refills
One integrated rare disease outcomes study, several partners, and the smallest investment producing the only significant refill lift.
Read case study → Case Study · Media EfficiencyCutting HCP Data Costs 70% Without Losing Engagement
Testing the precision premium on oncology audience data, and what happened to engagement when the savings moved into media.
Read case study → Case Study · Audience DataRetail Purchase Signal at 1/9th the Cost of Rx Claims
Ten data partners, one month, one measurement platform. Inmar retail signal reached verified patients at $2.88 vs an $11.71 blend.
Read case study → Case Study · AttributionDecoding Rx Attribution with Crossix and IQVIA
A challenge-approach-results case study, including a 31.5% visit-to-Rx conversion on a compressed seasonal launch.
Read case study →Foundational guides
The original long-form guides on the site: fundamentals, HCP targeting, measurement, CTV, compliance, and DSP selection.
The Ultimate Guide to Pharma Programmatic Advertising
A full primer on healthcare programmatic fundamentals, RTB mechanics, and where the channel is heading.
Read guide → Compliance ReferenceNavigating Pharma Advertising Compliance
An actionable guide to FDA, HIPAA, and brand safety controls for campaign planning.
Read compliance guide → Role GuideThe Role of a Pharma Programmatic Strategist
A hiring-focused view of responsibilities, competencies, and cross-functional leadership value.
Read role guide → Strategic PlaybookMastering HCP Targeting Best Practices
Designing NPI-informed audience strategy, contextual placements, and a weekly optimization cadence.
Read playbook → Identity & DataCookieless HCP Targeting
Why deterministic NPI targeting survives signal loss, where match graphs are fragile, and the identity stack to build now.
Read analysis → Measurement FrameworkHow Programmatic Media Drives Rx Outcomes
Crossix, IQVIA, target-list reach, conversion lift, and the measurement architecture behind Rx attribution.
Read framework → Planning ReferencePharma Programmatic Benchmarks
The directional CPM, match rate, reach, and visit-to-Rx planning numbers I actually use, with honest caveats.
See benchmarks → Measurement · Publisher DataWhat "Publisher Has Not Implemented Quantcast Measurement" Means
Why a site shows estimated instead of measured audience data, and what a buyer should ask for when direct measurement is missing.
Read article → Channel StrategyPharma CTV Advertising: The Streaming Playbook
NPI-matched HCP streaming, DTC contextual buys, fair balance in video, inventory quality, and Rx measurement.
Read playbook → DTC StrategyDTC Programmatic Activation in Pharma
Channel mix, compliance-aware targeting, and outcomes measurement that goes beyond clicks.
Read article → Category Deep DiveGLP-1 DTC Advertising Strategy
What pharma's loudest category teaches media teams about demand, competition, compliance, and measurement.
Read deep dive → DSP ComparisonDeepIntent vs IQVIA vs PulsePoint for Pharma
Healthcare targeting, compliance, measurement, and pharma-specific DSP capabilities compared side by side.
Compare DSPs →Hiring for a pharma programmatic role? See the case studies, try the live planning tool, or grab the résumé.